Marker Therapeutics, Inc. (MRKR)
1.52
+0.05
(+3.40%)
USD |
NASDAQ |
Feb 24, 11:19
Marker Therapeutics Market Cap : 25.34M for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 3.765B |
| Viridian Therapeutics, Inc. | 2.809B |
| ACADIA Pharmaceuticals, Inc. | 4.186B |
| Kiniksa Pharmaceuticals International Plc | 3.403B |
| Neurocrine Biosciences, Inc. | 13.02B |
Market Cap Related Metrics
| PS Ratio | 4.121 |
| PEG Ratio | -0.0906 |
| Price to Book Value | 1.378 |
| Price | 1.52 |
| Earnings Yield | -80.86% |
| PEGY Ratio | -0.0906 |